339 related articles for article (PubMed ID: 33392633)
1. Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance.
Wang H; Lu Y; Wang M; Wu Y; Wang X; Li Y
J Mol Med (Berl); 2021 Feb; 99(2):193-212. PubMed ID: 33392633
[TBL] [Abstract][Full Text] [Related]
2. Role of E3 ubiquitin ligases in gastric cancer.
Hou YC; Deng JY
World J Gastroenterol; 2015 Jan; 21(3):786-93. PubMed ID: 25624711
[TBL] [Abstract][Full Text] [Related]
3. Emerging roles of the HECT E3 ubiquitin ligases in gastric cancer.
Sun A; Tian X; Chen Y; Yang W; Lin Q
Pathol Oncol Res; 2023; 29():1610931. PubMed ID: 36825281
[TBL] [Abstract][Full Text] [Related]
4. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.
Zhou X; Jin W; Jia H; Yan J; Zhang G
J Exp Clin Cancer Res; 2015 Mar; 34(1):28. PubMed ID: 25888377
[TBL] [Abstract][Full Text] [Related]
5. Functional roles of E3 ubiquitin ligases in gastric cancer.
Wang M; Dai W; Ke Z; Li Y
Oncol Lett; 2020 Oct; 20(4):22. PubMed ID: 32774495
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle regulatory E3 ubiquitin ligases as anticancer targets.
Pray TR; Parlati F; Huang J; Wong BR; Payan DG; Bennett MK; Issakani SD; Molineaux S; Demo SD
Drug Resist Updat; 2002 Dec; 5(6):249-58. PubMed ID: 12531181
[TBL] [Abstract][Full Text] [Related]
7. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
Liu L; Wong CC; Gong B; Yu J
Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
[TBL] [Abstract][Full Text] [Related]
8. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers.
Masumoto K; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119
[TBL] [Abstract][Full Text] [Related]
9. The SCF-type E3 Ubiquitin Ligases as Cancer Targets.
Kitagawa K; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120
[TBL] [Abstract][Full Text] [Related]
10. FBXL5 attenuates RhoGDI2-induced cisplatin resistance in gastric cancer cells.
Wu WD; Wang M; Ding HH; Qiu ZJ
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2551-7. PubMed ID: 27383304
[TBL] [Abstract][Full Text] [Related]
11. RNF138 confers cisplatin resistance in gastric cancer cells via activating Chk1 signaling pathway.
Lu Y; Han D; Liu W; Huang R; Ou J; Chen X; Zhang X; Wang X; Li S; Wang L; Liu C; Miao S; Wang L; Ma C; Song W
Cancer Biol Ther; 2018; 19(12):1128-1138. PubMed ID: 30260263
[TBL] [Abstract][Full Text] [Related]
12. RBR E3 ubiquitin ligases in tumorigenesis.
Wang P; Dai X; Jiang W; Li Y; Wei W
Semin Cancer Biol; 2020 Dec; 67(Pt 2):131-144. PubMed ID: 32442483
[TBL] [Abstract][Full Text] [Related]
13. Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases.
Zhou W; Wei W; Sun Y
Cell Res; 2013 May; 23(5):599-619. PubMed ID: 23528706
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinase PSMD7 promotes the proliferation, invasion, and cisplatin resistance of gastric cancer cells by stabilizing RAD23B.
Wang J; Liu R; Mo H; Xiao X; Xu Q; Zhao W
Int J Biol Sci; 2021; 17(13):3331-3342. PubMed ID: 34512150
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.
Bielskienė K; Bagdonienė L; Mozūraitienė J; Kazbarienė B; Janulionis E
Medicina (Kaunas); 2015; 51(1):1-9. PubMed ID: 25744769
[TBL] [Abstract][Full Text] [Related]
16. The roles of E3 ligases in Hepatocellular carcinoma.
Yu Z; Li H; Zhu J; Wang H; Jin X
Am J Cancer Res; 2022; 12(3):1179-1214. PubMed ID: 35411231
[TBL] [Abstract][Full Text] [Related]
17. The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway.
Eto K; Iwatsuki M; Watanabe M; Ishimoto T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Baba H
Int J Cancer; 2015 Apr; 136(7):1537-45. PubMed ID: 25159729
[TBL] [Abstract][Full Text] [Related]
18. Role of E3 ubiquitin ligases in lung cancer.
Snoek BC; de Wilt LH; Jansen G; Peters GJ
World J Clin Oncol; 2013 Aug; 4(3):58-69. PubMed ID: 23936758
[TBL] [Abstract][Full Text] [Related]
19. DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.
Li J; Yu T; Yan M; Zhang X; Liao L; Zhu M; Lin H; Pan H; Yao M
Exp Cell Res; 2019 Jan; 374(2):304-314. PubMed ID: 30528265
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.
Li M; Zhang YY; Shang J; Xu YD
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4185-4191. PubMed ID: 31173289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
